SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015

被引:28
|
作者
Aranda, E. [1 ,2 ]
Aparicio, J. [3 ]
Alonso, V. [2 ,4 ]
Garcia-Albeniz, X. [5 ,6 ]
Garcia-Alfonso, P.
Salazar, R. [7 ]
Valladares, M. [8 ]
Vera, R. [9 ]
Vieitez, J. M. [2 ,10 ]
Garcia-Carbonero, R. [2 ,11 ]
机构
[1] Univ Cordoba, Hosp Reina Sofia, Inst Maimonides Invest Biomed IMIBIC, Serv Oncol Med, Cordoba, Spain
[2] Minist Econ & Competit, RTICC, ISCiii, Madrid, Spain
[3] Hosp Univ & Politecn La Fe, Valencia, Spain
[4] Hosp Univ Miguel Servet, Zaragoza, Spain
[5] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA USA
[6] Hosp Gen Univ Gregorio Maranon, Madrid, Spain
[7] Inst Catala Oncol LHospitalet, Barcelona, Spain
[8] Complexo Hosp Univ, La Coruna, Spain
[9] Complejo Hosp Navarra, Pamplona, Spain
[10] Hosp Univ Cent Asturias, Oviedo, Spain
[11] Hosp Univ 12 Octubre, Madrid, Spain
关键词
Colorectal cancer; Metastases; Chemotherapy; Targeted agents; Surgery; Guidelines; RANDOMIZED PHASE-III; 1ST-LINE TREATMENT; OPEN-LABEL; RAS MUTATIONS; COMBINATION CHEMOTHERAPY; IRINOTECAN FOLFIRI; PLUS CAPECITABINE; PANITUMUMAB PLUS; BEVACIZUMAB; FLUOROURACIL;
D O I
10.1007/s12094-015-1434-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colorectal cancer (CRC) is the second leading cause of cancer dead in Spain. About half the patients will eventually develop distant metastases. However, as treatment options are expanding, prognosis has steadily improved over the last decades. Management of advanced CRC should be discussed within an experienced multidisciplinary team to select the most appropriate systemic treatment (chemotherapy and targeted agents) and to integrate surgical or ablative procedures when indicated. Disease site and extent, resectability, tumor biology and gene mutations, clinical presentation, patient preferences, and comorbidities are key factors to design a customized treatment plan. The aim of these guidelines is to provide synthetic recommendations for managing advanced CRC patients.
引用
收藏
页码:972 / 981
页数:10
相关论文
共 50 条
  • [31] Clinical Effectiveness of Oncological Treatment in Metastatic Colorectal Cancer Is Independent of Comorbidities and Age
    Niedersuess-Beke, Dora
    Orlinger, Manuel
    Falch, David
    Heiler, Cordula
    Piringer, Gudrun
    Thaler, Josef
    Hilbe, Wolfgang
    Petzer, Andreas
    Rumpold, Holger
    CANCERS, 2021, 13 (09)
  • [32] Systemic treatment for metastatic colorectal cancer in the era of precision medicine
    Sandhu, Jaideep
    Lavingia, Viraj
    Fakih, Marwan
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 119 (05) : 564 - 582
  • [33] SEOM clinical guidelines for the treatment of early breast cancer
    Sonia del Barco Berrón
    Eva Ciruelos Gil
    Ignacio Tusquets Trías de Bes
    Montserrat Muñoz Mateu
    Pedro Sánchez Rovira
    Álvaro Rodríguez Lescure
    Dolores Isla Casado
    Clinical and Translational Oncology, 2010, 12 : 711 - 718
  • [34] The changing face of treatment for metastatic colorectal cancer
    Pfeiffer, Per
    Koehne, Claus-Henning
    Qvortrup, Camilla
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (01) : 61 - 70
  • [35] SEOM clinical guidelines for the treatment of early breast cancer
    del Barco Berron, Sonia
    Ciruelos Gil, Eva
    Trias de Bes, Ignacio Tusquets
    Munoz Mateu, Montserrat
    Sanchez Rovira, Pedro
    Rodriguez Lescure, Alvaro
    Isla Casado, Dolores
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (11) : 711 - 718
  • [36] Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015
    Price, Timothy J.
    Thavaneswaran, Subotheni
    Burge, Matthew
    Segelov, Eva
    Haller, Daniel G.
    Punt, Cornelis J. A.
    Arnold, Dirk
    Karapetis, Christos S.
    Tebbutt, Niall C.
    Pavlakis, Nick
    Gibbs, Peter
    Shapiro, Jeremy D.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (05) : 557 - 571
  • [37] SEOM clinical guidelines for the treatment of head and neck cancer
    Mesia Nin, Ricard
    Pastor Borgonon, Miguel
    Cruz Hernandez, Juan Jesus
    Isla Casado, Dolores
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (11) : 742 - 748
  • [38] SEOM Clinical Guidelines for the systemic treatment of early breast cancer 2013
    Del Barco, S.
    Ciruelos, E.
    Tusquets, I.
    Ruiz, M.
    Barnadas, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (12) : 1011 - 1017
  • [39] SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016)
    Martin-Richard, M.
    Diaz Beveridge, R.
    Arrazubi, V.
    Alsina, M.
    Galan Guzman, M.
    Custodio, A. B.
    Gomez, C.
    Munoz, F. L.
    Pazo, R.
    Rivera, F.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (12) : 1179 - 1186
  • [40] SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015
    R. García-Campelo
    R. Bernabé
    M. Cobo
    J. Corral
    J. Coves
    M. Dómine
    E. Nadal
    D. Rodriguez-Abreu
    N. Viñolas
    B. Massuti
    Clinical and Translational Oncology, 2015, 17 : 1020 - 1029